Radiographic disappearance of metastases could be a surrogate marker for outcomes among patients treated for metastatic ...

Investigators report findings from an analysis of 7836 robotic-assisted radical cystectomies performed from 2010 to 2021.

Cretostimogene is an oncolytic immunotherapy with dual mechanism of action: viral replication leading to tumor lysis and release of granulocyte-macrophage colony stimulating factor.

Investigators identify causative pathogens and risk factors for post-cystectomy UTI and associations with survival.

There is a high unmet need for effective neoadjuvant treatments for muscle-invasive bladder cancer for patients who cannot tolerate or refuse cisplatin chemotherapy.

Although the role of radiation therapy is well established in this setting, the role of radical prostatectomy in treating men with de novo oligometastatic prostate cancer has not been well defined.

More than 2 decades have passed since I became the first full-time editor of Renal & Urology News. During that time, the ...

Despite its complexity, partial nephrectomy still provides the best survival rates among treatment options in patients aged 75 years or older with T1-T2 renal cell carcinoma (RCC). Investigators ...

Active surveillance may be an appropriate option for older patients and those with greater comorbidity burden and worse ...

The FDA has approved Imfinzi® (durvalumab), in combination with gemcitabine and cisplatin, for the treatment of adult patients with MIBC.

The FDA expanded the approval of Pluvicto (lutetium Lu 177 vipivotide tetraxetan) to include patients with PSMA-positive mCRPC who have been treated with ARPI therapy and are considered appropriate to ...

Discrepancies between clinical and pathologic staging of muscle-invasive bladder cancer (MIBC) are found in three-quarters of ...